Tumour escape from the immune response: the last hurdle for successful immunotherapy of cancer?
Pawelec
G
G
Tübingen Ageing and Tumour Immunology Group, Section for Transplantation Immunology and Immunohaematology, Second Department of Internal Medicine, University of Tübingen Medical School, Otfried Müller-Strasse 10, D-72076 Tübingen, Germany.
D000951:Antigens, Neoplasm / Q000276:immunology; D019496:Cancer Vaccines / Q000276:immunology; D017635:Clonal Anergy / Q000276:immunology; D006680:HLA Antigens / Q000276:immunology; D006801:Humans; D007167:Immunotherapy; D009369:Neoplasms / Q000276:immunology* / Q000628:therapy*; D015398:Signal Transduction / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology; D019139:Tumor Escape / Q000276:immunology*
D000951:Antigens, Neoplasm; D019496:Cancer Vaccines; D006680:HLA Antigens